Phosphate homeostasis disorders

Area of Science:

• Endocrinology
• Genetics
• Nephrology

Background:

• Phosphate homeostasis is crucial for health.
• Genetic defects have been instrumental in uncovering key regulatory pathways.
• Fibroblast growth factor 23 (FGF23) has emerged as a central hormone in phosphate regulation.

Purpose of the Study:

• To summarize the impact of molecular identification of genetic disorders on understanding phosphate balance.
• To highlight the roles of FGF23 and associated molecules in mineral ion homeostasis.
• To discuss the clinical implications for treating FGF23-dependent conditions.

Main Methods:

• Review of genetic defects affecting phosphate homeostasis.
• Molecular identification and characterization of key regulatory proteins.
• Analysis of the interplay between FGF23, its regulators, and effectors.

Main Results:

• Identification of FGF23 as the primary phosphate-regulating hormone.
• Characterization of GALNT3, PHEX, DMP1, Klotho, NPT2a, and NPT2c in FGF23 regulation and action.
• Elucidation of the complex interactions between kidneys, bone, parathyroid, and gut.

Conclusions:

• Genetic insights have significantly advanced the understanding of phosphate regulation.
• Targeted treatments for FGF23-dependent hypophosphatemia have been developed.
• Dysregulation of mineral ion homeostasis in health and disease is better understood.